{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:11:28Z","timestamp":1792789888455,"version":"4.5.0"},"reference-count":217,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Kidney Foundation, Japan","award":["JKFB09-55"],"award-info":[{"award-number":["JKFB09-55"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Iron deficiency anemia (IDA) is a major problem in chronic kidney disease (CKD), causing increased mortality. Ferritin stores iron, representing iron status. Hepcidin binds to ferroportin, thereby inhibiting iron absorption\/efflux. Inflammation in CKD increases ferritin and hepcidin independent of iron status, which reduce iron availability. While intravenous iron therapy (IIT) is superior to oral iron therapy (OIT) in CKD patients with inflammation, OIT is as effective as IIT in those without. Inflammation reduces predictive values of ferritin and hepcidin for iron status and responsiveness to iron therapy. Upper limit of ferritin to predict iron overload is higher in CKD patients with inflammation than in those without. However, magnetic resonance imaging studies show lower cutoff levels of serum ferritin to predict iron overload in dialysis patients with apparent inflammation than upper limit of ferritin proposed by international guidelines. Compared to CKD patients with inflammation, optimal ferritin levels for IDA are lower in those without, requiring reduced iron dose and leading to decreased mortality. The management of IDA should differ between CKD patients with and without inflammation and include minimization of inflammation. Further studies are needed to determine the impact of inflammation on ferritin, hepcidin and therapeutic strategy for IDA in CKD.<\/jats:p>","DOI":"10.3390\/nu10091173","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T10:56:04Z","timestamp":1535367364000},"page":"1173","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":212,"title":["Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease"],"prefix":"10.3390","volume":"10","author":[{"given":"Norishi","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, Ishikawa 924-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Takasawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, Ishikawa 924-8588, Japan"},{"name":"Department of Internal Medicine, Public Tsurugi Hospital, Ishikawa 920-2134, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","article-title":"Iron deficiency anaemia","volume":"387","author":"Lopez","year":"2016","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/ejh.12776","article-title":"Epidemiology of iron deficiency anaemia in four European countries: A population-based study in primary care","volume":"97","author":"Levi","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrneph.2011.115","article-title":"Anemia in children with chronic kidney disease","volume":"7","author":"Atkinson","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/nep.12493","article-title":"Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study","volume":"20","author":"Iimori","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/nu3030283","article-title":"Iron, meat and health","volume":"3","author":"Geissler","year":"2011","journal-title":"Nutrients"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein","volume":"99","author":"Torti","year":"2002","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2014.114","article-title":"Association between hemoglobin variability, serum ferritin levels, and adverse events\/mortality in maintenance hemodialysis patients","volume":"86","author":"Kuragano","year":"2014","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000370317","article-title":"Low levels of serum ferritin lead to adequate hemoglobin levels and good survival in hemodialysis patients","volume":"40","author":"Ogawa","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zitt, E., Sturm, G., Kronenberg, F., Neyer, U., Knoll, F., Lhotta, K., and Weiss, G. (2014). Iron supplementation and mortality in incident dialysis patients: An observational study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114144"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: Regulation of mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","article-title":"Systemic iron homeostasis","volume":"93","author":"Ganz","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2174\/0929867324666170316120538","article-title":"Role of hepcidin-25 in chronic kidney disease: Anemia and beyond","volume":"24","author":"Ueda","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1096\/fj.201601326R","article-title":"It\u2019s time to redefine inflammation","volume":"31","author":"Antonelli","year":"2017","journal-title":"FASEB J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1626S","DOI":"10.3945\/ajcn.117.155937","article-title":"Assessment of iron status in settings of inflammation: Challenges and potential approaches","volume":"106","author":"Suchdev","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"c167","DOI":"10.1159\/000320116","article-title":"C-reactive protein and mortality in hemodialysis patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"117","author":"Kawaguchi","year":"2011","journal-title":"Nephron Clin. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0971-4065.70840","article-title":"Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy","volume":"20","author":"Jairam","year":"2010","journal-title":"Indian J. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.20452\/pamw.1458","article-title":"New parameters in iron metabolism and functional iron deficiency in patients on maintenance hemodialysis","volume":"122","author":"Kobus","year":"2012","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000368512","article-title":"Iron status and inflammation in early stages of chronic kidney disease","volume":"40","author":"Tobolczyk","year":"2015","journal-title":"Kidney Blood Press. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1053\/j.seminhematol.2013.06.006","article-title":"Anemia of chronic disease","volume":"50","author":"Gangat","year":"2013","journal-title":"Semin. Hematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000358336","article-title":"Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: A meta-analysis","volume":"39","author":"Susantitaphong","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1440-1797.2006.00676.x","article-title":"Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients","volume":"11","author":"Duncan","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.ki.5002223","article-title":"Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation","volume":"71","author":"Singh","year":"2007","journal-title":"Kidney Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/08860220903082606","article-title":"Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients: Potential role of prohepcidin, hepcidin, and inflammation","volume":"31","author":"Malyszko","year":"2009","journal-title":"Ren. Fail."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/SHK.0b013e31829266b9","article-title":"Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein","volume":"39","author":"Naz","year":"2013","journal-title":"Shock"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cell.2004.10.017","article-title":"Ferritin heavy chain upregulation by NF-kB inhibits TNF\u03b1-induced apoptosis by suppressing reactive oxygen species","volume":"119","author":"Pham","year":"2004","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1182\/blood.V91.3.1059","article-title":"Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: Role of selective iron regulatory protein-2 downregulation","volume":"91","author":"Recalcati","year":"1998","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000320733","article-title":"Importance of ferritin for optimizing anemia therapy in chronic kidney disease","volume":"32","author":"Nakanishi","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1172\/JCI67225","article-title":"Iron regulation by hepcidin","volume":"123","author":"Zhao","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12322","DOI":"10.1074\/jbc.M116.721191","article-title":"Neogenin facilitates the induction of hepcidin expression by hemojuvelin in the liver","volume":"291","author":"Zhao","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1074\/jbc.M114.611913","article-title":"Low intracellular iron increases the stability of matriptase-2","volume":"290","author":"Zhao","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2007-07-100677","article-title":"Furin-mediated release of soluble hemojuvelin: A new link between hypoxia and iron homeostasis","volume":"111","author":"Silvestri","year":"2008","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.toxrep.2015.01.004","article-title":"Effect of iron overload on furin expression in wild-type and \u03b2-thalassemic mice","volume":"2","author":"Wichaiyo","year":"2015","journal-title":"Toxicol. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1210\/en.2016-1258","article-title":"The SMAD pathway is required for hepcidin response during endoplasmic reticulum stress","volume":"157","author":"Canali","year":"2016","journal-title":"Endocrinology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood-2011-07-366690","article-title":"Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways","volume":"119","author":"Shin","year":"2012","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.1176639","article-title":"ER stress controls iron metabolism through induction of hepcidin","volume":"325","author":"Vecchi","year":"2009","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Meynard, D., Sun, C.C., Wu, Q., Chen, W., Chen, S., Nelson, C.N., Waters, M.J., Babitt, J.L., and Lin, H.Y. (2013). Inflammation regulates TMPRSS6 expression via STAT5. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082127"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1210\/me.2012-1345","article-title":"PGC-1\u03b1 regulates hepatic hepcidin expression and iron homeostasis in response to inflammation","volume":"27","author":"Qian","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10275","DOI":"10.1074\/jbc.M116.770974","article-title":"Interleukin-1\u03b2 (IL-1\u03b2) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein \u03b4 (C\/EBP\u03b4) expression in hepatocytes","volume":"292","author":"Kanamori","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1093\/ndt\/gfr044","article-title":"Iron overload as cardiovascular risk factor in children and adolescents with renal disease","volume":"26","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ndt\/gfg493","article-title":"Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients","volume":"19","author":"Rodriguez","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hayes, W. (2018). Measurement of iron status in chronic kidney disease. Pediatr. Nephrol.","DOI":"10.1007\/s00467-018-3955-x"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2005-03-1159","article-title":"Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS","volume":"106","author":"Kemna","year":"2005","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11255-011-9947-4","article-title":"Transferrin changes in haemodialysed patients","volume":"44","author":"Formanowicz","year":"2012","journal-title":"Int. Urol. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1111\/hdi.12556","article-title":"Markers of iron status in chronic kidney disease","volume":"21","author":"Gaweda","year":"2017","journal-title":"Hemodial. Int."},{"key":"ref_45","first-page":"107","article-title":"The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients","volume":"17","author":"Hackeng","year":"2004","journal-title":"J. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1523-1755.1999.00627.x","article-title":"Factors determining the percentage of hypochromic red blood cells in hemodialysis patients","volume":"56","author":"Bovy","year":"1999","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.05931108","article-title":"Hepcidin\u2014A potential novel biomarker for iron status in chronic kidney disease","volume":"4","author":"Zaritsky","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mercadal, L., Metzger, M., Haymann, J.P., Thervet, E., Boffa, J.J., Flamant, M., Vrtovsnik, F., Houillier, P., Froissart, M., and Stengel, B. (2014). The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099781"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2215\/CJN.08161109","article-title":"Reduction of serum hepcidin by hemodialysis in pediatric and adult patients","volume":"5","author":"Zaritsky","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ki.2010.254","article-title":"Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients","volume":"78","author":"Ford","year":"2010","journal-title":"Kidney Int."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation (2006). KDOQI Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am. J. Kidney Dis., 47, S11\u2013S145.","DOI":"10.1053\/j.ajkd.2006.03.011"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/ki.2008.269","article-title":"Clinical practice guidelines for assessment and management of iron deficiency","volume":"110","author":"Madore","year":"2008","journal-title":"Kidney Int. Suppl."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1744-9987.2010.00836.x","article-title":"2008 Japanese Society for Dialysis Therapy: Guidelines for renal anemia in chronic kidney disease","volume":"14","author":"Tsubakihara","year":"2010","journal-title":"Ther. Apher. Dial."},{"key":"ref_54","unstructured":"The Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group (2012). KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int. Suppl., 2, 279\u2013335."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney disease: Improving global outcomes guidelines on anaemia management in chronic kidney disease: A European Renal Best Practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/nep.12139","article-title":"KHA-CARI Guideline: Use of iron in chronic kidney disease patients","volume":"18","author":"Macginley","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/nep.12332","article-title":"Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines","volume":"19","author":"Hung","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"ref_58","unstructured":"National Clinical Guideline Centre (UK) (2015). Anaemia Management in Chronic Kidney Disease: Partial Update 2015. National Institute for Health and Care Excellence (NICE): Clinical Guideline, Loyal College of Physicians."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.ajkd.2015.11.012","article-title":"Diagnosis and management of iron deficiency in CKD: A summary of the NICE Guideline Recommendations and Their Rationale","volume":"67","author":"Ratcliffe","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Mikhail, A., Brown, C., Williams, J.A., Mathrani, V., Shrivastava, R., Evans, J., Isaac, H., and Bhandari, S. (2017). Renal association clinical practice guideline on anaemia of chronic kidney disease. BMC Nephrol., 18.","DOI":"10.1186\/s12882-017-0688-1"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/kisup.2015.6","article-title":"Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry","volume":"5","author":"Hamano","year":"2015","journal-title":"Kidney Int. Suppl."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.2215\/CJN.00710111","article-title":"C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients","volume":"6","author":"Bazeley","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/ndt\/gfn261","article-title":"Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study","volume":"23","author":"Ethier","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1053\/j.ajkd.2008.10.043","article-title":"Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: An instrumental variable analysis","volume":"53","author":"Pisoni","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1053\/j.ajkd.2014.07.010","article-title":"Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study","volume":"64","author":"Banerjee","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00467-011-1946-2","article-title":"Iron deficiency in children with early chronic kidney disease","volume":"26","author":"Baracco","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3945\/ajcn.2008.25926","article-title":"Unexplained decline in the prevalence of anemia among US children and women between 1988\u20131994 and 1999\u20132002","volume":"88","author":"Cusick","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10245332.2016.1240933","article-title":"Estimation of iron deficiency anemia in Iranian children and adolescents: A systematic review and meta-analysis","volume":"22","author":"Akbari","year":"2017","journal-title":"Hematology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2215\/CJN.01670408","article-title":"Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988\u20132004","volume":"4","author":"Fishbane","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ajh.24820","article-title":"Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management","volume":"92","author":"Cappellini","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_71","unstructured":"Centers for Disease Control and Prevention (CDC) (2002). Iron deficiency\u2014United States, 1999\u20132000. MMWR Morb. Mortal. Wkly. Rep., 51, 897\u2013899."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ijlh.12492","article-title":"Determination of functional iron deficiency status in haemodialysis patients in central South Africa","volume":"38","author":"Haupt","year":"2016","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_73","first-page":"605","article-title":"Clinical and economic outcomes in Medicare beneficiaries with stage 3 or stage 4 chronic kidney disease and anemia: The role of intravenous iron therapy","volume":"16","author":"Knight","year":"2010","journal-title":"J. Manag. Care Pharm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2215\/CJN.03980808","article-title":"Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease","volume":"4","author":"Kovesdy","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000191470","article-title":"Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients","volume":"29","author":"Bross","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000332395","article-title":"Risk factors associated with cardiovascular morbidity and mortality in Spanish incident hemodialysis patients: Two-year results from the ANSWER study","volume":"33","author":"Cuevas","year":"2012","journal-title":"Blood Purif."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000489223","article-title":"Association of pre-end-stage renal disease hemoglobin with early dialysis outcomes","volume":"47","author":"Kleine","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/ndt\/gfk095","article-title":"Anaemia and mortality in haemodialysis patients: Interaction of propensity score for predicted anaemia and actual haemoglobin levels","volume":"21","author":"Roberts","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1093\/ndt\/gfq073","article-title":"Mortality in incident haemodialysis patients: Time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study","volume":"25","author":"Fort","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1046\/j.1523-1755.64.s87.3.x","article-title":"Hemoglobin predicts long-term survival in dialysis patients: A 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin","volume":"87","author":"Avram","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ndt\/gfp550","article-title":"Relative risk of death in UK haemodialysis patients in relation to achieved haemoglobin from 1999 to 2005: An observational study using UK Renal Registry data incorporating 30,040 patient-years of follow-up","volume":"25","author":"Macdougall","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1017\/S000711451700040X","article-title":"Hb level, iron intake and mortality in Chinese adults: A 10-year follow-up study","volume":"117","author":"Shi","year":"2017","journal-title":"Br. J. Nutr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.kint.2016.09.013","article-title":"Hemoglobin of 12 g\/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis","volume":"91","author":"Rheault","year":"2017","journal-title":"Kidney Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/ndt\/gfm374","article-title":"Time to target haemoglobin concentration (11 g\/dl)\u2014Risk of hospitalization and mortality among incident dialysis patients","volume":"22","author":"Ishani","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10157-016-1317-1","article-title":"Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation","volume":"21","author":"Shoji","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.ajkd.2003.12.029","article-title":"A low serum iron level is a predictor of poor outcome in hemodialysis patients","volume":"43","author":"McAllister","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Koo, H.M., Kim, C.H., Doh, F.M., Lee, M.J., Kim, E.J., Han, J.H., Han, J.S., Oh, H.J., Park, J.T., and Han, S.H. (2014). The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087231"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.ajkd.2008.12.040","article-title":"Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients","volume":"53","author":"Lee","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10157-012-0659-6","article-title":"The impact of hyporesponsiveness to erythropoietin-stimulating agents on time-dependent mortality risk among CKD stage 5D patients: A single-center cohort study","volume":"17","author":"Ishigami","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1542-4758.2012.00700.x","article-title":"Left ventricular mass index and aortic arch calcification score are independent mortality predictors of maintenance hemodialysis patients","volume":"16","author":"Liu","year":"2012","journal-title":"Hemodial. Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/sdi.12168","article-title":"Iron and infection in hemodialysis patients","volume":"27","author":"Ishida","year":"2014","journal-title":"Semin. Dial."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MAJ.0b013e31818d8bbe","article-title":"Serum ferritin levels predict all-cause and infection-cause 1-year mortality in diabetic patients on maintenance hemodialysis","volume":"337","author":"Jenq","year":"2009","journal-title":"Am. J. Med. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000187285","article-title":"Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey","volume":"64","author":"Kessler","year":"1993","journal-title":"Nephron"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000438819","article-title":"Serum ferritin predicts mortality regardless of inflammatory and nutritional status in patients starting dialysis: A prospective cohort study","volume":"40","author":"Park","year":"2015","journal-title":"Blood Purif."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000478735","article-title":"Serum ferritin variations and mortality in incident hemodialysis patients","volume":"46","author":"Kim","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2015.07.026","article-title":"Comparative short-term safety of sodium ferric gluconate versus iron sucrose in hemodialysis patients","volume":"67","author":"Brookhart","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5414\/CNP57457","article-title":"Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients","volume":"57","author":"Hoen","year":"2002","journal-title":"Clin. Nephrol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","article-title":"FIND-CKD: A randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"Macdougall","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Regidor","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Karaboyas, A., Morgenstern, H., Pisoni, R.L., Zee, J., Vanholder, R., Jacobson, S.H., Inaba, M., Loram, L.C., Port, F.K., and Robinson, B.M. (2018). Association between serum ferritin and mortality: Findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study. Nephrol. Dial. Transplant.","DOI":"10.1093\/ndt\/gfy190"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ki.2014.419","article-title":"Development and validation of a predictive mortality risk score from a European hemodialysis cohort","volume":"87","author":"Floege","year":"2015","journal-title":"Kidney Int."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/jren.2003.50017","article-title":"C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: A 2-year prospective study","volume":"13","author":"Chauveau","year":"2003","journal-title":"J. Ren. Nutr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1523-1755.2003.00788.x","article-title":"A prospective cohort study of incident maintenance dialysis in children: An NAPRTC study","volume":"63","author":"Leonard","year":"2003","journal-title":"Kidney Int."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1523-1755.2004.00357.x","article-title":"Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients","volume":"65","author":"Chavers","year":"2004","journal-title":"Kidney Int."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1093\/ndt\/gfs178","article-title":"Prevalence and predictors of the sub-target Hb level in children on dialysis","volume":"27","author":"Krischock","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Dmitrieva, O., de Lusignan, S., Macdougall, I.C., Gallagher, H., Tomson, C., Harris, K., Desombre, T., and Goldsmith, D. (2013). Association of anaemia in primary care patients with chronic kidney disease: Cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data. BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-24"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.amjmed.2012.03.011","article-title":"Changing patterns of anemia management in US hemodialysis patients","volume":"125","author":"Freburger","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Miskulin, D.C., Zhou, J., Tangri, N., Bandeen-Roche, K., Cook, C., Ephraim, P.L., Crews, D.C., Scialla, J.J., Sozio, S.M., and Shafi, T. (2013). Trends in anemia management in US hemodialysis patients 2004\u20132010. BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-264"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1681\/ASN.2014090922","article-title":"Considerations and challenges in defining optimal iron utilization in hemodialysis","volume":"26","author":"Charytan","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/10245332.2017.1325587","article-title":"Kidney injury in infants and children with iron-deficiency anemia before and after iron treatment","volume":"22","author":"Hassan","year":"2017","journal-title":"Hematology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/j.ajkd.2008.05.029","article-title":"Erythropoietin, iron depletion, and relative thrombocytosis: A possible explanation for hemoglobin-survival paradox in hemodialysis","volume":"52","author":"Streja","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3945\/ajcn.114.103366","article-title":"Guidelines on the diagnosis and treatment of iron deficiency across indications: A systematic review","volume":"102","author":"Williet","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/nu7010103","article-title":"Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients","volume":"7","author":"Takasawa","year":"2015","journal-title":"Nutrients"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Peters, N.O., Jay, N., Cridlig, J., Rostoker, G., and Frimat, L. (2017). Targets for adapting intravenous iron dose in hemodialysis: A proof of concept study. BMC Nephrol., 18.","DOI":"10.1186\/s12882-017-0513-x"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2008.05.033","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: Systematic review and meta-analysis","volume":"52","author":"Paul","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_116","first-page":"CD007857","article-title":"Parenteral versus oral iron therapy for adults and children with chronic kidney disease","volume":"1","author":"Albaramki","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ndt\/gfq613","article-title":"A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"Qunibi","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/gfu357","article-title":"Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: A randomized trial","volume":"30","author":"Pisani","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000096174","article-title":"A randomized controlled trial of oral versus intravenous iron in chronic kidney disease","volume":"26","author":"Agarwal","year":"2006","journal-title":"Am. J. Nephrol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ndt\/gfv293","article-title":"A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia","volume":"31","author":"Kalra","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5414\/CN109198","article-title":"Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial","volume":"88","author":"Macdougall","year":"2017","journal-title":"Clin. Nephrol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1742-1241.2006.01166.x","article-title":"Effectiveness of oral and intravenous iron therapy in haemodialysis patients","volume":"62","author":"Jenq","year":"2008","journal-title":"Int. J. Clin. Pract."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/16.5.967","article-title":"A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin","volume":"16","author":"Stoves","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Takasawa, K., Takaeda, C., Wada, T., and Ueda, N. (2018). Optimal serum ferritin levels for iron deficiency anemia during oral iron therapy (OIT) in Japanese hemodialysis patients with minor inflammation and benefit of intravenous iron therapy for OIT-nonresponders. Nutrients, 10.","DOI":"10.3390\/nu10040428"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Ogawa, C., Tsuchiya, K., Tomosugi, N., Kanda, F., Maeda, K., and Maeda, T. (2017). Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179608"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2169\/internalmedicine.8520-16","article-title":"Beneficial effects of oral iron in Japanese patients on hemodialysis","volume":"56","author":"Sanai","year":"2017","journal-title":"Intern. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ndt\/13.1.82","article-title":"Iron absorption in erythropoietin-treated haemodialysis patients: Effects of iron availability, inflammation and aluminium","volume":"13","author":"Kooistra","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10157-012-0694-3","article-title":"Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?","volume":"16","author":"Nakanishi","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1755.1998.00032.x","article-title":"C-reactive protein as an outcome predictor for maintenance hemodialysis patients","volume":"54","author":"Owen","year":"1998","journal-title":"Kidney Int."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1742-1241.2002.tb11309.x","article-title":"The effects of acute phase proteins on serum albumin, transferrin and haemoglobin in haemodialysis patients","volume":"56","author":"Kalender","year":"2002","journal-title":"Int. J. Clin. Pract."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10157-014-1048-0","article-title":"A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients","volume":"19","author":"Heidari","year":"2015","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/ndt\/gfn172","article-title":"Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients","volume":"23","author":"Chan","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1076029612454935","article-title":"Progressive increase of inflammatory biomarkers in chronic kidney disease and end-stage renal disease","volume":"19","author":"Sharain","year":"2013","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3109\/0886022X.2014.937663","article-title":"The relationship of prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: A controlled study","volume":"36","author":"Aydin","year":"2014","journal-title":"Ren. Fail."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5414\/CN109132","article-title":"Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study","volume":"89","author":"Goyal","year":"2018","journal-title":"Clin. Nephrol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5455\/medarh.2013.67.361-364","article-title":"The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis","volume":"67","author":"Musanovic","year":"2013","journal-title":"Med. Arch."},{"key":"ref_137","first-page":"45","article-title":"Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO)","volume":"49","author":"Saltissi","year":"1998","journal-title":"Clin. Nephrol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/ard.59.3.217","article-title":"Anaemia in systemic lupus erythematosus: Aetiological profile and the role of erythropoietin","volume":"59","author":"Voulgarelis","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1002\/art.30623","article-title":"Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia","volume":"63","author":"Laarakkers","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5152\/eurjrheumatol.2014.032","article-title":"The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus","volume":"1","author":"Seyhan","year":"2014","journal-title":"Eur. J. Rheumatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"6843976","DOI":"10.1155\/2017\/6843976","article-title":"Anti-TNF-mediated modulation of prohepcidin improves iron availability in inflammatory bowel disease, in an IL-6-mediated fashion","volume":"2017","author":"Cavallaro","year":"2017","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/CEOR.S150900","article-title":"Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany\u2014A real-world evidence analysis","volume":"10","author":"Stein","year":"2018","journal-title":"Clinicoecon. Outcomes Res."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Kronbichler, A., and Mayer, G. (2013). Renal involvement in autoimmune connective tissue diseases. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-95"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.04660513","article-title":"The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease","volume":"9","author":"Ambruzs","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"R182","DOI":"10.1186\/ar4012","article-title":"Inflammation associated anemia and ferritin as disease markers in SLE","volume":"14","author":"Vanarsa","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/0961203314552290","article-title":"Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE","volume":"24","author":"Tripathy","year":"2015","journal-title":"Lupus"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0022-3859.188550","article-title":"Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?","volume":"63","author":"Umare","year":"2017","journal-title":"J. Postgrad. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/ard.2004.022681","article-title":"Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia","volume":"64","author":"Ripley","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/jcla.21685","article-title":"A study of hepcidin and monocyte chemoattractant protein-1 in Egyptian females with systemic lupus erythematosus","volume":"28","author":"Mohammed","year":"2014","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ki.2011.354","article-title":"A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies","volume":"81","author":"Zhang","year":"2012","journal-title":"Kidney Int."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2169\/internalmedicine.48.1578","article-title":"Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis","volume":"48","author":"Demirag","year":"2009","journal-title":"Intern. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ecco-jcc\/jjv242","article-title":"Serum hepcidin and iron absorption in paediatric inflammatory bowel disease","volume":"10","author":"Martinelli","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10620-014-3460-4","article-title":"Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia","volume":"60","author":"Iqbal","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.9.4.358","article-title":"Oral and intravenous iron therapy in the anaemia of rheumatoid arthritis","volume":"9","author":"Ross","year":"1950","journal-title":"Ann. Rheum. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1081\/JDI-120005364","article-title":"Total dose infusion iron dextran therapy in predialysis chronic renal failure patients","volume":"24","author":"Anuradha","year":"2002","journal-title":"Ren. Fail."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2215\/CJN.01070308","article-title":"Combined high serum ferritin and low iron saturation in hemodialysis patients: The role of inflammation","volume":"3","author":"Rambod","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_157","first-page":"93","article-title":"Impact of inflammation on anemia of hemodialysis patients who were under treatment of recombinant human erythropoietin","volume":"2","author":"Nasri","year":"2013","journal-title":"J. Ren. Inj. Prev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1093\/ndt\/gfq321","article-title":"Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents","volume":"25","author":"Tessitore","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Gaillard, C.A., Bock, A.H., Carrera, F., Eckardt, K.U., Van Wyck, D.B., Bansal, S.S., Cronin, M., Meier, Y., Larroque, S., and Roger, S.D. (2016). Hepcidin response to iron therapy in patients with non-dialysis dependent CKD: An analysis of the FIND-CKD trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157063"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.transproceed.2003.11.054","article-title":"Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy","volume":"36","author":"Yavuz","year":"2004","journal-title":"Transplant. Proc."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/ndt\/gfr431","article-title":"Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: A cross-sectional study","volume":"27","author":"Uehata","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40620-014-0083-y","article-title":"Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease","volume":"28","author":"Chand","year":"2015","journal-title":"J. Nephrol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bcmd.2016.05.006","article-title":"Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose","volume":"59","author":"Drakou","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2215\/CJN.00420107","article-title":"Role of oral iron in the management of long-term hemodialysis patients","volume":"2","author":"Lenga","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3892\/etm.2010.122","article-title":"Effectiveness of oral iron to manage anemia in long-term hemodialysis patients with the use of ultrapure dialysate","volume":"1","author":"Tsuchida","year":"2010","journal-title":"Exp. Ther. Med."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Nagaraju, S.P., Cohn, A., Akbari, A., Davis, J.L., and Zimmerman, D.L. (2013). Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: A randomized controlled trial. BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-64"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/ndt\/gfv096","article-title":"A randomized, open-label trial of iron isomaltoside 1000 (Monofer\u00ae) compared with iron sucrose (Venofer\u00ae) as maintenance therapy in haemodialysis patients","volume":"30","author":"Bhandari","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Rostoker, G., Griuncelli, M., Loridon, C., Magna, T., Machado, G., Drahi, G., Dahan, H., Janklewicz, P., and Cohen, Y. (2015). Reassessment of iron biomarkers for prediction of dialysis iron overload: An MRI study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132006"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/00015385.2017.1335382","article-title":"Ferrokinetics is associated with the left ventricular mass index in patients with chronic kidney disease","volume":"72","author":"Tanaka","year":"2017","journal-title":"Acta Cardiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s11255-015-1090-1","article-title":"Serum ferritin is associated with arterial stiffness in hemodialysis patients: Results of a 3-year follow-up study","volume":"47","author":"Lin","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1536\/ihj.46.255","article-title":"Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease","volume":"46","author":"Reis","year":"2005","journal-title":"Int. Heart J."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5527\/wjn.v2.i2.38","article-title":"Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients","volume":"2","author":"Hsieh","year":"2013","journal-title":"World J. Nephrol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/ndt\/gfq760","article-title":"Hepcidin as well as TNF-\u03b1 are significant predictors of arterial stiffness in patients on maintenance hemodialysis","volume":"26","author":"Kuragano","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.4103\/0366-6999.156781","article-title":"Serum hepcidin predicts uremic accelerated atherosclerosis in chronic hemodialysis patients with diabetic nephropathy","volume":"128","author":"Li","year":"2015","journal-title":"Chin. Med. J. (Engl.)"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Mostovaya, I.M., Bots, M.L., van den Dorpel, M.A., Goldschmeding, R., den Hoedt, C.H., Kamp, O., Levesque, R., Mazairac, A.H., Penne, E.L., and Swinkels, D.W. (2014). Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the COnvective TRansport STudy (CONTRAST). PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084587"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfs488","article-title":"Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients","volume":"28","author":"Grooteman","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nephro.2014.02.005","article-title":"Therapy of anemia and iron deficiency in dialysis patients: An update","volume":"10","author":"Rostoker","year":"2014","journal-title":"Nephrol. Ther."},{"key":"ref_178","first-page":"S125","article-title":"Clinical practice guidelines on iron therapy: A critical evaluation","volume":"21","author":"Locatelli","year":"2017","journal-title":"Hemodial. Int."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/ndt\/12.12.2801","article-title":"Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin","volume":"12","author":"Abdalla","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/ndt\/gfh136","article-title":"Low-dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients","volume":"19","author":"Canavese","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Rostoker, G., Griuncelli, M., Loridon, C., Magna, T., Janklewicz, P., Drahi, G., Dahan, H., and Cohen, Y. (2014). Maximal standard dose of parenteral iron for hemodialysis patients: An MRI-based decision tree learning analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0115096"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semnephrol.2016.02.005","article-title":"Safety issues in iron treatment in CKD","volume":"36","author":"Vaziri","year":"2016","journal-title":"Semin. Nephrol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2215\/CJN.00080116","article-title":"Iron therapy challenges for the treatment of nondialysis CKD patients","volume":"11","author":"Locatelli","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2015.163","article-title":"A randomized trial of intravenous and oral iron in chronic kidney disease","volume":"88","author":"Agarwal","year":"2015","journal-title":"Kidney Int."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"f4822","DOI":"10.1136\/bmj.f4822","article-title":"Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: Systematic review and meta-analysis of randomised clinical trials","volume":"347","author":"Litton","year":"2013","journal-title":"BMJ"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2014.275","article-title":"Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality","volume":"87","author":"Bailie","year":"2015","journal-title":"Kidney Int."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2215\/CJN.03370414","article-title":"Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network Patient Outcomes in End Stage Renal Disease Study Investigators. Intravenous iron exposure and mortality in patients on hemodialysis","volume":"9","author":"Miskulin","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease","volume":"106","author":"Massy","year":"2002","journal-title":"Circulation"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5414\/CNP75472","article-title":"The effects of oral iron supplementation on the progression of anemia and renal dysfunction in patients with chronic kidney disease","volume":"75","author":"Kim","year":"2011","journal-title":"Clin. Nephrol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.ki.5002422","article-title":"Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease","volume":"72","author":"Agarwal","year":"2007","journal-title":"Kidney Int."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/ndt\/gfl789","article-title":"Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2\u2032-deoxyguanosine levels","volume":"22","author":"Maruyama","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10157-011-0584-0","article-title":"The impact of ferritin fluctuations on stable hemoglobin levels in hemodialysis patients","volume":"16","author":"Yahiro","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ki.2010.459","article-title":"Anemia management under a bundled payment policy for dialysis: A preview for the United States from Japan","volume":"79","author":"Wish","year":"2011","journal-title":"Kidney Int."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000445424","article-title":"High ferritin level and malnutrition predict high risk of infection-related hospitalization in incident dialysis patients: A Japanese prospective cohort study","volume":"42","author":"Kato","year":"2016","journal-title":"Blood Purif."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1111\/hdi.12555","article-title":"Diagnosing and preventing iron overload","volume":"21","author":"Ramanathan","year":"2017","journal-title":"Hemodial. Int."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.2012.01783.x","article-title":"Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron","volume":"89","author":"Ghoti","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.amjmed.2012.02.009","article-title":"Epidemic of iron overload in dialysis population caused by intravenous iron products: A plea for moderation","volume":"125","author":"Vaziri","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0272-6386(03)00658-9","article-title":"Clinical evaluation of heme iron polypeptide: Sustaining a response to rHuEPO in hemodialysis patients","volume":"42","author":"Nissenson","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000450696","article-title":"Oral low-dose ferric citrate is a useful iron source for hyperphosphatemic hemodialysis patients: A case series","volume":"43","author":"Tanemoto","year":"2017","journal-title":"Blood Purif."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semnephrol.2016.02.004","article-title":"Iron treatment strategies in dialysis-dependent CKD","volume":"36","author":"Pandey","year":"2016","journal-title":"Semin. Nephrol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1525-1594.2010.01037.x","article-title":"The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents","volume":"35","author":"Malovrh","year":"2011","journal-title":"Artif. Organs"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1080\/0886022X.2016.1184937","article-title":"Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients","volume":"38","author":"Deira","year":"2016","journal-title":"Ren. Fail."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/ndt\/gfl419","article-title":"Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients","volume":"21","author":"Schiesser","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Strauss, W.E., Dahl, N.V., Li, Z., Lau, G., and Allen, L.F. (2016). Ferumoxytol versus iron sucrose treatment: A post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia. BMC Hematol., 16.","DOI":"10.1186\/s12878-016-0060-x"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"c81","DOI":"10.1159\/000253958","article-title":"Low-molecular-weight iron dextran in the management of renal anaemia in patients on haemodialysis-the IDIRA Study","volume":"114","author":"Rath","year":"2010","journal-title":"Nephron Clin. Pract."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ki.2015.203","article-title":"Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients","volume":"88","author":"Gupta","year":"2015","journal-title":"Kidney Int."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1440-1797.2009.01203.x","article-title":"Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease","volume":"15","author":"Ferrari","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.kint.2016.07.019","article-title":"Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease","volume":"90","author":"Pergola","year":"2016","journal-title":"Kidney Int."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000464476","article-title":"Clinical trial of vadadustat in patients with anemia secondary to stage 3 or 4 chronic kidney disease","volume":"45","author":"Martin","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/ndt\/gfv302","article-title":"Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients","volume":"30","author":"Besarab","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1681\/ASN.2015030241","article-title":"Roxadustat (FG-4592): Correction of anemia in incident dialysis patients","volume":"27","author":"Besarab","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1053\/j.ajkd.2015.11.021","article-title":"A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: A 28-day, phase 2a randomized trial","volume":"67","author":"Brigandi","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.2215\/CJN.03090509","article-title":"Biochemistry and biomarkers of inflamed patients: Why look, what to assess","volume":"4","author":"Kaysen","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_215","first-page":"693","article-title":"Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients\u2014A prospective cross-over study","volume":"17","author":"Hsu","year":"2004","journal-title":"J. Nephrol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ndt\/gfr686","article-title":"Obesity and iron deficiency in chronic kidney disease: The putative role of hepcidin","volume":"27","author":"Sarafidis","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1824-7288-37-34","article-title":"Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: A case control study","volume":"37","author":"Sanad","year":"2011","journal-title":"Ital. J. Pediatr."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/9\/1173\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:21:22Z","timestamp":1760196082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/9\/1173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":217,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["nu10091173"],"URL":"https:\/\/doi.org\/10.3390\/nu10091173","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,27]]}}}